Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00097240
Status:
COMPLETED
Last Update Posted:
2010-08-04
First Post:
2004-11-19
Brief Title:
An Observational Study of the Use and Safety of Raptiva During Pregnancy FOLLOW
Sponsor:
Genentech Inc
Organization:
Genentech Inc
Study Overview
Official Title:
The Raptiva Pregnancy Registry An Observational Study of the Use and Safety of Raptiva Efalizumab During Pregnancy
Status:
COMPLETED
Status Verified Date:
2010-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FOLLOW
Brief Summary:
The Raptiva Pregnancy Registry was a prospective observational study established to obtain data on pregnancy outcomes of women who were exposed to Raptiva
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None